Virtu Financial’s Esperion Therapeutics ESPR Stock Holding History

Virtu Financial’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51K	Buy	+16,262	New	+$45.5K	﹤0.01%	1223
2025 Q3	–	Sell	-76,622	Closed	-$75K	–	1639
2025 Q2	$75K	Buy	76,622 +40,713	+113%	+$40.8K	﹤0.01%	1075
2025 Q1	$52K	Sell	35,909 -96,325	-73%	-$177K	﹤0.01%	1006
2024 Q4	$291K	Buy	+132,234	New	+$309K	0.02%	708
2023 Q4	–	Sell	-181,597	Closed	-$178K	–	1681
2023 Q3	$178K	Buy	+181,597	New	+$263K	0.02%	691
2021 Q3	–	Sell	-13,480	Closed	-$285K	–	1636
2021 Q2	$285K	Buy	+13,480	New	+$325K	0.03%	756
2017 Q4	–	Sell	-12,458	Closed	-$624K	–	2504
2017 Q3	$624K	Buy	+12,458	New	+$601K	0.03%	745

Other funds holding ESPR

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Virtu Financial's ESPR Position: Q2 2026 in Review

Virtu Financial opened a new position in Esperion Therapeutics (ESPR) in Q2 2026: 16,262 shares worth $51K. The stake represents ﹤0.01% of the portfolio and ranks #1223 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ESPR as recently as Q2 2025.

Virtu Financial first reported a position in ESPR in Q3 2017 and has held it in 7 quarters since. The position peaked at $624K in Q3 2017. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

Virtu Financial held 16,262 shares of Esperion Therapeutics worth $51K as of Q2 2026.
Esperion Therapeutics was a new Virtu Financial position in Q2 2026.
Esperion Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1223 holding.
Virtu Financial first reported a position in Esperion Therapeutics in Q3 2017 and has held it in 7 quarters since.
Virtu Financial's Esperion Therapeutics position peaked at $624K in Q3 2017.
191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.